Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of "eye stroke" (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side ...

The FDA said it is giving Novo Nordisk two weeks to notify it of the actions it will take to prevent future violations. In a statement published online, Novo Nordisk said it has b ...

The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.

Weight loss drug giant Novo Nordisk has received a warning letter from the U.S. Food and Drug Administration for failing to report side effects potentially linked to Ozempic usage, including two ...

Novo Nordisk A/S got a warning letter from the US Food and Drug Administration for not reporting all suspected side effects in patients who took its blockbuster Ozempic.

Researchers at University of California San Diego School of Medicine have found that a natural fungal supplement taken at the ...

It’s worth the weight — loss, that is. Despite their blockbuster popularity, GLP-1 medications come with a handful of side effects, mainly along the lines of gastrointestinal issues like nausea and ...

A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their labels. Memory problems, depression, sleep issues, weight gain, and many ...

Patients worried about potential side effects of statins can rest easy, according to a new large-scale study: The vast majority of adverse effects listed on statin medications simply never occur. The ...

The long list of side effects marked on the packaging of statins can be a turn-off for those who might benefit from the cholesterol-lowering drugs. But a new study found only a few of those side ...

New research suggests that it’s rare to experience most of the listed side effects for this common type of cholesterol-lowering medication. Misconceptions that statins come with a high risk of side ...